CD8A and relapsing-remitting multiple sclerosis: Collectively, these data showed the ability of EM and TEMRA CD8 T cell subsets of patients with RRMS to adapt their metabolism to engage their effector function, and therefore, the selective susceptibility of CD8 T cells of patients with RRMS to DHODH inhibition was not related to impaired CD8 T cell energy metabolism.